NASDAQ
BioNexus Gene Lab Corp. (BGLC) has a interest coverage ratio of -161.62x as of Wednesday, July 15, 2026. This represents a 219.15% decrease compared to its 12-month average of -50.64x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.
No price data available for this timeframe.